Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
High-grade serous ovarian cancer (HGSC) remains the most common and deadly subtype of ovarian cancer. It is characterized by its late diagnosis and frequent relapse despite standardized treatment with cytoreductive surgery and platinum-based chemotherapy. The past decade has seen significant advance...
Main Authors: | Melissa Bradbury, Eva Borràs, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Anna Santamaria, Eduard Sabidó |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2067 |
Similar Items
-
A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management
by: Melissa Bradbury, et al.
Published: (2022-12-01) -
Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01) -
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
by: Sabine Kasimir-Bauer, et al.
Published: (2020-09-01) -
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
by: Joohyun Ryu, et al.
Published: (2021-05-01) -
Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
by: Tova M. Bergsten, et al.
Published: (2022-11-01)